Haleon is beefing up its stake in Chinese OTC joint venture TSKF and has secured an option to take full control of the business in the future.
Haleon Strengthens Control Of China JV, Agrees Option To Buy
Joint venture business which markets Haleon's OTC drug brands in China will soon be 88% owned by the UK-based firm.